{
    "2021-07-01": [
        [
            {
                "time": "2021-07-02",
                "original_text": "Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Single-Shot",
                        "COVID-19 Vaccine",
                        "Delta Variant",
                        "Long-lasting Durability"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-07-02",
                "original_text": "Delta variant sparks concerns, future mutations remain a threat",
                "features": {
                    "keywords": [
                        "Delta Variant",
                        "Concerns",
                        "Future Mutations",
                        "Threat"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}